Correlation Between Clearpoint Neuro and Hyperfine
Can any of the company-specific risk be diversified away by investing in both Clearpoint Neuro and Hyperfine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clearpoint Neuro and Hyperfine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Clearpoint Neuro and Hyperfine, you can compare the effects of market volatilities on Clearpoint Neuro and Hyperfine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clearpoint Neuro with a short position of Hyperfine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clearpoint Neuro and Hyperfine.
Diversification Opportunities for Clearpoint Neuro and Hyperfine
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Clearpoint and Hyperfine is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Clearpoint Neuro and Hyperfine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hyperfine and Clearpoint Neuro is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clearpoint Neuro are associated (or correlated) with Hyperfine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hyperfine has no effect on the direction of Clearpoint Neuro i.e., Clearpoint Neuro and Hyperfine go up and down completely randomly.
Pair Corralation between Clearpoint Neuro and Hyperfine
Given the investment horizon of 90 days Clearpoint Neuro is expected to under-perform the Hyperfine. But the stock apears to be less risky and, when comparing its historical volatility, Clearpoint Neuro is 3.28 times less risky than Hyperfine. The stock trades about -0.01 of its potential returns per unit of risk. The Hyperfine is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 99.00 in Hyperfine on November 28, 2024 and sell it today you would lose (2.00) from holding Hyperfine or give up 2.02% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Clearpoint Neuro vs. Hyperfine
Performance |
| Timeline |
| Clearpoint Neuro |
| Hyperfine |
Clearpoint Neuro and Hyperfine Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Clearpoint Neuro and Hyperfine
The main advantage of trading using opposite Clearpoint Neuro and Hyperfine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clearpoint Neuro position performs unexpectedly, Hyperfine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hyperfine will offset losses from the drop in Hyperfine's long position.| Clearpoint Neuro vs. Avita Medical | Clearpoint Neuro vs. Sight Sciences | Clearpoint Neuro vs. Treace Medical Concepts | Clearpoint Neuro vs. Neuropace |
| Hyperfine vs. Neuropace | Hyperfine vs. Orthopediatrics Corp | Hyperfine vs. Anika Therapeutics | Hyperfine vs. PAVmed Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |